FAKTOR-OPTIONSSCHEIN - IPSEN | Market Closed - Börse Stuttgart 14:49:09 2024-06-07 EDT | ||
| 19.7 EUR | +0.77% |
|
| Current month | +7.83% | ||
| 1 month | +36.52% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
Latest news about IPSEN
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 19.7 | +0.77% |
| 24-06-06 | 19.55 | -1.26% |
| 24-06-05 | 19.8 | +4.93% |
| 24-06-04 | 18.87 | +7.09% |
| 24-06-03 | 17.62 | -3.56% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 02:49 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MG0HJ1 |
| ISIN | DE000MG0HJ17 |
| Date issued | 2024-03-20 |
| Strike | 98.26 € |
| Maturity | Unlimited |
| Parity | 1.24 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 20.4 € |
|---|---|
| Lowest since issue | 9.71 € |
| Spread | 0.62 € |
| Spread % | 3.07% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
122.9
EUR
Average target price
126.4
EUR
Spread / Average Target
+2.85%
- Stock Market
- Certificates
- Certificat
